131 related articles for article (PubMed ID: 23861541)
1. CCAAT/enhancer binding protein δ in macrophages contributes to immunosuppression and inhibits phagocytosis in nasopharyngeal carcinoma.
Hsiao YW; Li CF; Chi JY; Tseng JT; Chang Y; Hsu LJ; Lee CH; Chang TH; Wang SM; Wang DD; Cheng HC; Wang JM
Sci Signal; 2013 Jul; 6(284):ra59. PubMed ID: 23861541
[TBL] [Abstract][Full Text] [Related]
2. CCAAT/enhancer binding protein (C/EBP) delta promotes the expression of PTX3 and macrophage phagocytosis during A. fumigatus infection.
Liu L; Zhong J; Chen B; Wang W; Xi H; Su X
J Leukoc Biol; 2022 Jun; 111(6):1225-1234. PubMed ID: 34939225
[TBL] [Abstract][Full Text] [Related]
3. CCAAT/enhancer binding protein delta (CEBPD) elevating PTX3 expression inhibits macrophage-mediated phagocytosis of dying neuron cells.
Ko CY; Chang LH; Lee YC; Sterneck E; Cheng CP; Chen SH; Huang AM; Tseng JT; Wang JM
Neurobiol Aging; 2012 Feb; 33(2):422.e11-25. PubMed ID: 21112127
[TBL] [Abstract][Full Text] [Related]
4. CEBPD Potentiates the Macrophage Inflammatory Response but CEBPD Knock-Out Macrophages Fail to Identify CEBPD-Dependent Pro-Inflammatory Transcriptional Programs.
Spek CA; Aberson HL; Butler JM; de Vos AF; Duitman J
Cells; 2021 Aug; 10(9):. PubMed ID: 34571881
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-1β (IL-1β) transcriptionally activates hepcidin by inducing CCAAT enhancer-binding protein δ (C/EBPδ) expression in hepatocytes.
Kanamori Y; Murakami M; Sugiyama M; Hashimoto O; Matsui T; Funaba M
J Biol Chem; 2017 Jun; 292(24):10275-10287. PubMed ID: 28438835
[TBL] [Abstract][Full Text] [Related]
6. Lipopolysaccharide-induced transcriptional activation of interleukin-10 is mediated by MAPK- and NF-kappaB-induced CCAAT/enhancer-binding protein delta in mouse macrophages.
Liu YW; Chen CC; Tseng HP; Chang WC
Cell Signal; 2006 Sep; 18(9):1492-500. PubMed ID: 16413748
[TBL] [Abstract][Full Text] [Related]
7. Targeting chemotherapy-induced PTX3 in tumor stroma to prevent the progression of drug-resistant cancers.
Chi JY; Hsiao YW; Li CF; Lo YC; Lin ZY; Hong JY; Liu YM; Han X; Wang SM; Chen BK; Tsai KK; Wang JM
Oncotarget; 2015 Sep; 6(27):23987-4001. PubMed ID: 26124179
[TBL] [Abstract][Full Text] [Related]
8. Peptidoglycan enhances transcriptional expression of CCAAT/enhancer-binding protein delta gene in mouse macrophages.
Huang YC; Chang WC; Su JG; Cai JL; Chen CC; Hung JJ; Liu YW
J Biomed Sci; 2007 May; 14(3):407-18. PubMed ID: 17273900
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-6 and mevastatin regulate plasminogen activator inhibitor-1 through CCAAT/enhancer-binding protein-delta.
Dong J; Fujii S; Li H; Nakabayashi H; Sakai M; Nishi S; Goto D; Furumoto T; Imagawa S; Zaman TA; Kitabatake A
Arterioscler Thromb Vasc Biol; 2005 May; 25(5):1078-84. PubMed ID: 15718495
[TBL] [Abstract][Full Text] [Related]
10. PTX3 function as an opsonin for the dectin-1-dependent internalization of zymosan by macrophages.
Diniz SN; Nomizo R; Cisalpino PS; Teixeira MM; Brown GD; Mantovani A; Gordon S; Reis LF; Dias AA
J Leukoc Biol; 2004 Apr; 75(4):649-56. PubMed ID: 14726497
[TBL] [Abstract][Full Text] [Related]
11. Promoter methylation reduces C/EBPdelta (CEBPD) gene expression in the SUM-52PE human breast cancer cell line and in primary breast tumors.
Tang D; Sivko GS; DeWille JW
Breast Cancer Res Treat; 2006 Jan; 95(2):161-70. PubMed ID: 16322893
[TBL] [Abstract][Full Text] [Related]
12. CCAAT/enhancer binding protein delta (C/EBPδ) demonstrates a dichotomous role in tumour initiation and promotion of epithelial carcinoma.
Sowamber R; Chehade R; Bitar M; Dodds LV; Milea A; Slomovitz B; Shaw PA; George SHL
EBioMedicine; 2019 Jun; 44():261-274. PubMed ID: 31078521
[TBL] [Abstract][Full Text] [Related]
13. Direct interaction of C/EBPdelta and Sp1 at the GC-enriched promoter region synergizes the IL-10 gene transcription in mouse macrophage.
Chiang BT; Liu YW; Chen BK; Wang JM; Chang WC
J Biomed Sci; 2006 Sep; 13(5):621-35. PubMed ID: 16871431
[TBL] [Abstract][Full Text] [Related]
14. The C/EBPδ protein is stabilized by estrogen receptor α activity, inhibits SNAI2 expression and associates with good prognosis in breast cancer.
Mendoza-Villanueva D; Balamurugan K; Ali HR; Kim SR; Sharan S; Johnson RC; Merchant AS; Caldas C; Landberg G; Sterneck E
Oncogene; 2016 Dec; 35(48):6166-6176. PubMed ID: 27181204
[TBL] [Abstract][Full Text] [Related]
15. Eicosapentaenoic acid demethylates a single CpG that mediates expression of tumor suppressor CCAAT/enhancer-binding protein delta in U937 leukemia cells.
Ceccarelli V; Racanicchi S; Martelli MP; Nocentini G; Fettucciari K; Riccardi C; Marconi P; Di Nardo P; Grignani F; Binaglia L; Vecchini A
J Biol Chem; 2011 Aug; 286(31):27092-102. PubMed ID: 21659508
[TBL] [Abstract][Full Text] [Related]
16. CCAAT/enhancer-binding protein δ (C/EBPδ) aggravates inflammation and bacterial dissemination during pneumococcal meningitis.
Valls Serón M; Duitman J; Geldhoff M; Engelen-Lee J; Havik SR; Brouwer MC; van de Beek D; Spek CA
J Neuroinflammation; 2015 May; 12():88. PubMed ID: 25958220
[TBL] [Abstract][Full Text] [Related]
17. High-Throughput Screening for CEBPD-Modulating Compounds in THP-1-Derived Reporter Macrophages Identifies Anti-Inflammatory HDAC and BET Inhibitors.
Ullmann T; Luckhardt S; Wolf M; Parnham MJ; Resch E
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33809617
[TBL] [Abstract][Full Text] [Related]
18. Identification of a Src tyrosine kinase/SIAH2 E3 ubiquitin ligase pathway that regulates C/EBPδ expression and contributes to transformation of breast tumor cells.
Sarkar TR; Sharan S; Wang J; Pawar SA; Cantwell CA; Johnson PF; Morrison DK; Wang JM; Sterneck E
Mol Cell Biol; 2012 Jan; 32(2):320-32. PubMed ID: 22037769
[TBL] [Abstract][Full Text] [Related]
19. Nasopharyngeal carcinoma progression is mediated by EBER-triggered inflammation via the RIG-I pathway.
Duan Y; Li Z; Cheng S; Chen Y; Zhang L; He J; Liao Q; Yang L; Gong Z; Sun LQ
Cancer Lett; 2015 May; 361(1):67-74. PubMed ID: 25721089
[TBL] [Abstract][Full Text] [Related]
20. CCAAT/Enhancer binding protein delta (c/EBPdelta) regulation and expression in human mammary epithelial cells: I. "Loss of function" alterations in the c/EBPdelta growth inhibitory pathway in breast cancer cell lines.
Sivko GS; DeWille JW
J Cell Biochem; 2004 Nov; 93(4):830-43. PubMed ID: 15389879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
